| Literature DB >> 29563869 |
Daihong Liu1, Shanshan Duan2, Chaoyang Zhou1, Ping Wei3, Lihua Chen1, Xuntao Yin1, Jiuquan Zhang1, Jian Wang1.
Abstract
Type 2 diabetes mellitus (T2DM) affects a vast population and is closely associated with cognitive impairment. However, the mechanisms of cognitive impairment in T2DM patients have not been unraveled. Research on the basic units (nodes or hubs and edges) of the brain functional network on the basis of neuroimaging may advance our understanding of the network change pattern in T2DM patients. This study investigated the change patterns of brain functional hubs using degree centrality (DC) analysis and the connectivity among these hubs using functional connectivity and Granger causality analysis. Compared to healthy controls, the DC values were higher in the left anterior cingulate gyrus (ACG) and lower in the bilateral lateral occipital cortices (LOC) and right precentral gyrus (PreCG) in T2DM patients. The functional connectivity between the left ACG and the right PreCG was stronger in T2DM patients, whereas the functional connectivity among the right PreCG and bilateral LOC was weaker. A negative causal effect from the left ACG to left LOC and a positive effect from the left ACG to right LOC were observed in T2DM patients, while in healthy controls, the opposite occurred. Additionally, the reserve of normal brain function in T2DM patients was negatively associated with the elevated glycemic parameters. This study demonstrates that there are brain functional hubs and connectivity alterations that may reflect the aberrant information communication in the brain of T2DM patients. The findings may advance our understanding of the mechanisms of T2DM-related cognitive impairment.Entities:
Keywords: Granger causality analysis; cognitive impairment; degree centrality; functional connectivity; resting-state functional MRI; type 2 diabetes mellitus
Year: 2018 PMID: 29563869 PMCID: PMC5845755 DOI: 10.3389/fnagi.2018.00055
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Demographic and clinical data of the subjects.
| Age (years) | 58.66 ± 6.87 | 57.36 ± 5.42 | 0.312 |
| Sex (male:female) | 28/19 | 25/22 | 0.533 |
| Education (years) | 10.60 ± 3.06 | 10.77 ± 2.65 | 0.773 |
| T2DM duration (years) | 8.87 ± 6.61 | – | – |
| BMI (kg/m2) | 25.46 ± 5.11 | 23.94 ± 3.87 | 0.109 |
| Gray matter (cm3) | 608.15 ± 58.00 | 615.16 ± 51.67 | 0.538 |
| White matter (cm3) | 534.91 ± 64.85 | 524.16 ± 66.56 | 0.430 |
| Brain parenchyma (cm3) | 1143.06 ± 114.78 | 1139.32 ± 107.80 | 0.871 |
| Systolic blood pressure (mmHg) | 128.91 ± 16.81 | 134.55 ± 17.88 | 0.119 |
| Diastolic blood pressure (mmHg) | 79.49 ± 10.01 | 80.26 ± 10.25 | 0.715 |
| HbA1c (%) | 8.26 ± 2.08 | 5.63 ± 0.39 | <0.001 |
| HbA1c (mmol/mol) | 66.76 ± 22.80 | 38.15 ± 4.33 | <0.001 |
| Fasting plasma glucose (mmol/L) | 7.47 ± 2.70 | 5.22 ± 0.46 | <0.001 |
| Fasting insulin (mIU/L) | 14.91 (9.58, 24.54) | 11.41 (8.39, 17.10) | 0.035 |
| Fasting C-peptide (ng/mL) | 1.81 ± 1.05 | 2.22 ± 0.90 | 0.047 |
| HOMA2-IR | 0.28 (0.19, 0.52) | 0.21 (0.16, 0.32) | 0.015 |
| Total cholesterol (mmol/L) | 4.89 ± 1.04 | 5.10 ± 1.02 | 0.325 |
| Triglyceride (mmol/L) | 1.45 (1.05, 1.98) | 1.23 (0.91, 1.48) | 0.023 |
| HDL cholesterol (mmol/L) | 1.06 ± 0.23 | 1.41 ± 0.36 | <0.001 |
| LDL cholesterol (mmol/L) | 3.16 ± 0.83 | 3.27 ± 0.76 | 0.489 |
| Homocysteine (μmol/L) | 16.62 ± 10.03 | 10.70 ± 4.10 | <0.001 |
| Blood urea nitrogen (mmol/L) | 6.36 ± 2.45 | 5.72 ± 1.23 | 0.113 |
| Serum creatine (μmol/L) | 65.00 (57.00, 78.00) | 78.00 (66.00, 85.00) | 0.007 |
| Cystatin C (mg/L) | 0.72 (0.64, 0.91) | 0.76 (0.69, 0.86) | 0.639 |
| Uric acid (μmol/L) | 316.67 ± 79.72 | 328.34 ± 69.09 | 0.450 |
| Free triiodothyronine, FT3 (pmol/L) | 4.31 ± 0.91 | 5.13 ± 0.72 | <0.001 |
| Free thyroxine, FT4 (pmol/L) | 15.52 ± 2.34 | 16.48 ± 1.89 | 0.032 |
| Thyroid-stimulating hormone, TSH (mIU/L) | 2.12 ± 0.95 | 2.57 ± 1.54 | 0.090 |
p < 0.05 indicates statistical significance.
χ.
Mann-Whitney U-test for non-normally distributed data [median (QR)]. Independent t-test for the other normally distributed continuous data (means ± SD). T2DM, type 2 diabetes mellitus; HC, healthy control; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Comparison of the neuropsychological test results between the two groups.
| MMSE | 29.00 (27.00, 29.00) | 29.00 (28.00, 29.00) | 0.203 |
| MoCA | 23.17 ± 2.88 | 24.51 ± 2.31 | 0.015 |
| TMT-A | 74.67 ± 41.11 | 64.17 ± 32.59 | 0.173 |
| TMT-B | 183.19 ± 89.90 | 142.00 ± 58.35 | 0.010 |
| VFT | 42.17 ± 7.33 | 40.55 ± 7.05 | 0.279 |
| DST forwards | 8.83 ± 1.37 | 9.60 ± 1.50 | 0.011 |
| DST backwards | 4.00 (3.00, 5.00) | 4.00 (3.00, 4.00) | 0.911 |
| AVLT immediate recall | 6.46 ± 1.69 | 6.86 ± 1.49 | 0.226 |
| AVLT short-term delayed recall | 6.77 ± 3.18 | 7.74 ± 2.41 | 0.096 |
| AVLT long-term delayed recall | 5.40 ± 3.77 | 6.72 ± 2.43 | 0.047 |
| AVLT long-term delayed recognition | 11.00 (8.00, 13.00) | 12.00 (9.00, 13.00) | 0.327 |
| AVLT total score | 28.97 ± 9.94 | 32.34 ± 7.45 | 0.065 |
p < 0.05 was considered statistically significant.
Mann-Whitney U-test for non-normally distributed data [median (QR)]. Independent t-test for the other normally distributed continuous data (means ± SD). MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test; VFT, Verbal Fluency Test; DST, Digital Span Test; AVLT, Auditory Verbal Learning Test.
Figure 1DC value distribution of intra-group and inter-group comparisons. (A,B) The spatial distribution of the DC value in the HC group and T2DM group. (C) The significantly altered DC map in the T2DM group. (D) Comparison of DC value between the two groups. AlphaSim corrected (p < 0.001, cluster size > 20 voxels). The color bar denotes the t-value. Error bars define the SEM. ACG, anterior cingulate gyrus; LOC, lateral occipital cortices; PreCG, precentral gyrus; R, right; L, left.
Brain regions with significant DC differences between the two groups.
| 1 | Left anterior cingulate gyrus | 32 | −9 | 42 | 9 | 3.1455 | 28 |
| 2 | Right lateral occipital cortex | 19 | 27 | −78 | 24 | −3.1327 | 20 |
| 3 | Left lateral occipital cortex | 19 | −24 | −84 | 21 | −3.9907 | 147 |
| 4 | Right precentral gyrus | 43 | 63 | −3 | 30 | −3.4576 | 55 |
MNI, Montreal Neurological Institute; BA, Broadmann Area. R, Right; L, left; AlphaSim corrected (p < 0.001, cluster > 20 voxels).
Figure 2FC pattern of intra-group and inter-group comparisons. (A,B) The FC pattern in the HC group and T2DM group. (C) The significantly altered FC in the T2DM group. (D) Comparison of FC z scores between the two groups. *p < 0.05, #p < 0.05/6 (Bonferroni correction). Error bars define the SEM. ACG, anterior cingulate gyrus; LOC, lateral occipital cortices; PreCG, precentral gyrus; R, right; L, left.
Figure 3GCA pattern of intra-group and inter-group comparisons. (A,B) Causal effect patterns of the HC group and T2DM group. The red arrow indicates a positive casual effect and its direction. The blue arrow indicates a negative casual effect and its direction. (C) Comparison of signed-path coefficients between the two groups. *p < 0.05. Error bars define the SEM.
Figure 4Correlations among the connectivity, neuropsychological performance and diabetes-related parameters. (A) Signed-path coefficients of the left ACG to the left LOC vs. C-peptide (ng/mL). (B) DST forwards vs. HbA1c(%).